Monopar Therapeutics (MNPR) had the highest return on October 24 by a US stock, returning 537.9%.

ASSET	DATE	% RETURN
Monopar Therapeutics (MNPR)	10/24/2024	537.89%
error (ZVZZT)	10/24/2024	179.72%
Nexalin Technology (NXLIW)	10/24/2024	100%
Klotho Neurosciences (KLTOW)	10/24/2024	57.14%
Nexalin Technology (NXL)	10/24/2024	56.93%
AlphaVest Acquisition Corp Right (ATMVR)	10/24/2024	49.85%
Alpha Technology Group Limited Ordinary Shares (ATGL)	10/24/2024	47.33%
Helport AI Limited Warrants (HPAIW)	10/24/2024	44.44%
Top Wealth Group Holding Limited Ordinary Shares (TWG)	10/24/2024	44.23%
Gogoro Equity Warrant Exp 4th April 2027 (GGROW)	10/24/2024	42.36%
Quince Therapeutics (QNCX)	10/24/2024	35.38%
Nova Minerals Limited Warrant (NVAWW)	10/24/2024	33.33%
Auddia (AUUDW)	10/24/2024	33.33%
Lixiang Education (LXEH)	10/24/2024	32.88%
Iron Horse Acquisitions Corp Warrant (IROHW)	10/24/2024	31.58%
Swvl Holdings Corp Warrant (SWVLW)	10/24/2024	30.99%
NLS Pharmaceutics (NLSPW)	10/24/2024	30.69%
Advent Technologies (ADNWW)	10/24/2024	30.67%
USA Rare Earth (USARW)	10/24/2024	30.43%
Edible Garden (EDBLW)	10/24/2024	30%
PureCycle Technologies (PCTTW)	10/24/2024	29.46%
Hycroft Mining (HYMCL)	10/24/2024	28.57%
Purecycle Technologies (PCT)	10/24/2024	28.25%
ABVC BioPharma (ABVC)	10/24/2024	26.14%
Aligos Therapeutics (ALGS)	10/24/2024	26.12%